Termeer protege scores $27M for Genzyme rare disease spinoff
November 16, 2017 at 07:00 AM EST
Paula Ragan worked at Genzyme for nearly six years before founding X4 Pharmaceuticals along with longtime CEO Henri Termeer and others.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.